当前位置:首页 - 行情中心 - 海创药业-U(688302) - 财务分析 - 现金流量表

海创药业-U

(688302)

  

流通市值:50.38亿  总市值:61.19亿
流通股本:8151.51万   总股本:9901.56万

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金13,016,2905,000414,350364,240
  收到的税费返还---412,484.03
  收到其他与经营活动有关的现金25,983,333.784,894,824.8720,605,074.4316,121,107.17
  经营活动现金流入小计38,999,623.784,899,824.8721,019,424.4316,897,831.2
  购买商品、接受劳务支付的现金2,152,824.82547,833.11292,186.69270,000
  支付给职工以及为职工支付的现金37,333,856.0417,131,967.1570,143,751.6454,305,218.63
  支付的各项税费507,824.6174,301.97438,447.2294,522.11
  支付其他与经营活动有关的现金46,433,160.1822,400,628.7137,228,097.71102,007,643.68
  经营活动现金流出小计86,427,665.6540,154,730.93208,102,483.24156,877,384.42
  经营活动产生的现金流量净额-47,428,041.87-35,254,906.06-187,083,058.81-139,979,553.22
二、投资活动产生的现金流量:
  收回投资收到的现金1,300,050,000350,050,0003,945,000,0002,775,000,000
  取得投资收益收到的现金4,064,380.13938,215.5314,037,537.259,942,325.82
  处置固定资产、无形资产和其他长期资产收回的现金净额--2,175.57100
  收到的其他与投资活动有关的现金34,740,430.6622,885,515.86--
  投资活动现金流入小计1,338,854,810.79373,873,731.393,959,039,712.822,784,942,425.82
  购建固定资产、无形资产和其他长期资产支付的现金41,503,612.826,661,483.3189,549,635.6109,932,395.23
  投资支付的现金1,310,050,000720,050,0003,865,000,0002,905,000,000
  支付其他与投资活动有关的现金8,698,614.46,656,910.9734,740,430.66-
  投资活动现金流出小计1,360,252,227.2753,368,394.283,989,290,066.263,014,932,395.23
  投资活动产生的现金流量净额-21,397,416.41-379,494,662.89-30,250,353.44-229,989,969.41
三、筹资活动产生的现金流量:
  取得借款收到的现金100,000,000---
  筹资活动现金流入平衡项目0---
  筹资活动现金流入小计100,000,000---
  分配股利、利润或偿付利息支付的现金---386,144.54
  支付其他与筹资活动有关的现金1,842,424.981,220,156.494,056,3172,821,921.15
  筹资活动现金流出小计1,842,424.981,220,156.494,056,3173,208,065.69
  筹资活动产生的现金流量净额98,157,575.02-1,220,156.49-4,056,317-3,208,065.69
四、汇率变动对现金及现金等价物的影响-339,461.45-135,438.331,427,097.07-1,077,377.44
五、现金及现金等价物净增加额28,992,655.29-416,105,163.77-219,962,632.18-374,254,965.76
  加:期初现金及现金等价物余额593,226,056.49593,226,056.49813,188,688.67813,188,688.67
  期末现金及现金等价物余额622,218,711.78177,120,892.72593,226,056.49438,933,722.91
补充资料:
  净利润-61,853,200.96--199,495,736.1-
  固定资产和投资性房地产折旧1,392,215.42-2,070,963.01-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧1,392,215.42-2,070,963.01-
  长期待摊费用摊销--41,232.53-
  处置固定资产、无形资产和其他长期资产的损失--1,063.8-
  公允价值变动损失-2,054,220.43--3,962,834.76-
  财务费用-956,367.24--3,983,228.64-
  投资损失-1,843,351.3--9,144,656.32-
  存货的减少-1,048,631.03-1,019.34-
  经营性应收项目的减少-6,598,876.25-5,918,932.58-
  经营性应付项目的增加16,164,333.26--7,542,197.07-
  其他7,029,599.25-24,789,767.04-
  现金的期末余额622,218,711.78-593,226,056.49-
  减:现金的期初余额593,226,056.49-813,188,688.67-
  现金及现金等价物的净增加额28,992,655.29--219,962,632.18-
公告日期2025-08-142025-04-262025-04-192024-10-26
审计意见(境内)标准无保留意见
TOP↑